Delivery Order SPE2DR25D2206-SPE2DR26F9BL4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $1,859.50 and a firm fixed price. This competitively awarded, non-set-aside contract is classified as a delivery order and is scheduled for completion by June 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $37,190. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a $5,578.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zoladex 10.8 mg implant syringes, with completion scheduled for October 14, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $2,789.25. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $3,719.00 and ultimate completion date of October 1, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,297.50 on August 12, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract carries firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $1,985.82 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a specific procurement requirement under a broader contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $3,971.64 and an ultimate completion date of October 14, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $1,859.50 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 2, 2025, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,157.00 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of October 8, 2025. This non-competitive, firm fixed-price delivery order was issued on September 17, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9BL4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Zoladex 10.8 mg implant syringes under a firm fixed-price contract with a ceiling value of $5,879. This competitively awarded, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to federal medical procurement needs. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999 through December 2026. This primary vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices to support military healthcare programs globally. Through this contract structure, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key strategic vendor within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 11/13/25 |